PROFUND ADVISORS LLC

Position in VNDA — Vanda Pharmaceuticals Inc.

CIK 1129919 BETHESDA, MD

Position in VNDA

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$196,470

-$88,422 QoQ

Shares Held

32,103

-22.1% QoQ

Ownership

0.053%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#82

of 172 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. VNDA ranks #153 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$196,470	32,103	-22.1%	Shares	Sole	2026-08-11
2026-03-31	$284,892	41,229	-3.3%	Shares	Sole	2026-04-27
2023-06-30	$281,023	42,644	-6.7%	Shares	Sole	2023-08-10
2023-03-31	$310,201	45,685	+320.9%	Shares	Sole	2023-05-12
2021-06-30 ALXN	—	57,295	-2.3%	Shares	Sole	2021-08-12
2021-06-30	$233,491	10,855	—	Shares	Sole	2021-08-12
2021-03-31 ALXN	—	58,622	-2.1%	Shares	Sole	2021-05-14
2020-12-31 ALXN	—	59,900	+8.1%	Shares	Sole	2021-02-09
2020-09-30 ALXN	—	55,397	-12.4%	Shares	Sole	2020-11-13
2020-06-30 ALXN	—	63,212	+13.9%	Shares	Sole	2020-08-03
2020-03-31 ALXN	—	55,483	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.